Trump’s Drug-Pricing Push to Cut Access Outside US, Study Finds

A study found that the Trump administration's policies to reduce US drug spending create incentives for pharmaceutical companies to raise prices and limit access in other countries. The research examined how cost-control measures in the US market affect global pharmaceutical pricing strategies. The study did not name specific administration policies or provide implementation dates.

Next story